Form 8-K - Current report:
SEC Accession No. 0000886163-18-000115
Filing Date
2018-08-09
Accepted
2018-08-09 09:05:39
Documents
5
Period of Report
2018-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K us-docsx102817630xv3ligand.htm 8-K 30794
2 EXHIBIT 2.1 exhibit21-rule27announcment.htm EX-2.1 377645
3 EXHIBIT 10.1 exhibit101co-operationagre.htm EX-10.1 190118
4 EXHIBIT 10.2 exhibit102breakfeeletter.htm EX-10.2 28309
5 exhibit101cooperation_image1.gif GRAPHIC 14614
  Complete submission text file 0000886163-18-000115.txt   648306
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 181003641
SIC: 2834 Pharmaceutical Preparations